Why the weight-loss drugs battle will intensify in 2026, explained in 5 charts
Novo executives project that oral pills could capture more than a third of the total obesity drug market…
Novo’s Wegovy pill to test demand from consumers with cash – The Irish Times
Novo Nordisk’s newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying…